|
ADF Archive Files : For Browse View Click Here
Roger Kilham - Access Economics Canberra
Australian Medical Association National Conference 1999
Policy Discussion Group
May 1999
My tasks in this talk are to:
The best overview of household (non-tax) health spending is found in AIHW's Health Expenditure Bulletins. Table 1 shows the latest - 1995-96 - data.
| Table 1: Health expenditure by households, 1995-96 ($m) | |||
|---|---|---|---|
| Via PHI | Out of pocket | Total | |
| Public hospitals | 380 | 380 | |
| Private hospitals | 2,231 | 293 | 2,524 |
| Repatriation hospitals | 0 | 0 | 0 |
| Public psychiatric hospitals | 0 | 13 | 13 |
| Sub-total hospitals | 2,611 | 306 | 2,917 |
| Nursing homes | 0 | 677 | 677 |
| Ambulance | 91 | 71 | 162 |
| Other non-institutional nec | 0 | 0 | 0 |
| Sub-total non-hospital institutional | 91 | 748 | 839 |
| Sub-total institutional | 2,702 | 1,054 | 3,756 |
| Medical services | 223 | 757 | 980 |
| Other professional services | 215 | 758 | 973 |
| Benefit paid pharmaceuticals | 0 | 493 | 493 |
| All other pharmaceuticals | 44 | 1,569 | 1,613 |
| Sub-total pharmaceuticals | 44 | 2,062 | 2,106 |
| Aids and appliances | 172 | 438 | 610 |
| Community and public health | 2 | 0 | 2 |
| Dental services | 564 | 1,149 | 1,713 |
| Administration | 504 | 0 | 504 |
| Research | 0 | 125 | 125 |
| Sub-total non-institutional | 1,724 | 5,289 | 7,013 |
| Recurrent health spending by households | 4,426 | 6,343 | 10,769 |
| National recurrent health spending | 38,951 | ||
| Household spending as a percentage of national spending | 27.6% | ||
| Source: AIHW, Health Expenditure Bulletin Number 14, December 1998, Table 35. | |||
In 1995-96, households spent $10.8 billion on health care, representing 28% of national health spending. Of this $10.8 billion, $4.4 billion was paid in private health insurance premiums and $6.3 billion was spent out of pocket.
Just over half the out-of-pocket expenses-$3.2 billion-went on pharmaceuticals and dental care. Medical services accounted for only 12 % of the total.
| Table 2: Out-of-pocket health expenditure by households, 1995-96 ($m) | ||
|---|---|---|
| $m | % total | |
| Pharmaceuticals | 2,062 | 32.5% |
| Dental services | 1,149 | 18.1% |
| Other professional services | 758 | 12.0% |
| Medical services | 757 | 11.9% |
| Nursing homes | 677 | 10.7% |
| Aids and appliances | 438 | 6.9% |
| Private hospitals | 293 | 4.6% |
| Research | 125 | 2.0% |
| Ambulance | 71 | 1.1% |
| Public psychiatric hospitals | 13 | 0.2% |
| Recurrent health spending by households | 6,343 | 100.0% |
| Source: As for Table 1. | ||
The focus of our discussion today is medical gaps related to private health insurance, that is, privately provided in-hospital medical services. In 1995-96, these were of the order of $200 million.
Now lets look at it from a Medicare perspective, again using 1995-96 figures:
| Amount paid by the PHI funds | $223 million |
| Patient out-of-pocket re in-hospital medical services | $200 million |
| Total household funded in-hospital services | $423 million |
| Patient out-of-pocket re out-of-hospital medical services | $561 million |
| Total household funded medical gaps | $984 million |
| Source: Medicare Statistics, unpublished Medicare data, PHIAC annual report. | |
The corresponding figures for 1997-98 are:
| Amount paid by the PHI funds | $228 million |
| Patient out-of-pocket re in-hospital medical services | $250 million |
| Total household funded in-hospital services | $478 million |
| Patient out-of-pocket re out-of-hospital medical services | $649 million |
| Total household funded medical gaps | $1,127 million |
| Source: Medicare Statistics, unpublished Medicare data, PHIAC annual report | |
The total fee charged, as recorded in the Medicare statistics is the total amount invoiced. We do not know how much of it is paid, and by inference, we do not know how much of the out-of-pocket amount of $250 million is paid. It is just the upper limit. The data indicate that some 20% of private in-hospital non-compensable services are by self-insured (ie, uninsured) patients. $200 million of the $250 million is therefore a top-of-the range estimate of the out-of-pocket amounts met by people with private health insurance. At face value, this is a trivial amount. It represents:
If the monetary level of the gap determined its importance, we could finish this discussion group before 12, beat all the other groups to lunch and spend the afternoon on the golf course or in the bar.
Significance Of Gaps
The medico-political importance of medical gaps far outweighs their dollar value. In the push for managed care, the then Labor Federal Government and the Funds made medical gaps a big political issue, constantly talking them way up beyond their monetary significance and never mentioning the numerically larger hospital gaps. This fanned member discontent, harming private health insurance coverage, but it did save the funds money because it increased the incentive for PHI members to avoid gap payments by seeking admission as public patients.
The gaps are not just a political issue, they are also an economic and social issue. The purpose of all insurance is to enable the sharing of risk. The purpose of health insurance is to enable people to share the financial risk of bad health. If insurers are prevented by government intervention from insuring their members for the cost of services at their market prices, their ability to spread the risk is curtailed. The $650 million of out-of-hospital gaps is distributed across the whole community. The $200 million of PHI-related in-hospital gaps is very unevenly spread, concentrated on a minority of the privately insured population who, in turn, represent only 30% of the population. Furthermore, they are unevenly spread among the group who incur them. I know two people who incurred out-of-pocket costs of some $10,000 each despite having private insurance.
In economic terminology, this is not a case of market failure. Rather, it is market impairment. Government regulation of the private health insurance industry has impaired its ability to carry out its insurance-its risk sharing-function. This makes private insurance a less attractive product. Government intervention has impaired the economic efficiency of the private health insurance market In a social context, that intervention has produced outcomes which consumers consider to be very inequitable. Many current and erstwhile fund members are angry. They dislike the "octo-whammy", being bitten eight times, having to pay for health care through Federal taxes, State and local taxes, the Medicare levy, PHI fund premiums, medical gaps, hospital gaps, pharmaceutical gaps and gaps on aids and appliances. While medical Medicare itself remains relatively simple, it is quite a different matter if you wish to use private hospital care.
Another imperfection of the private health insurance market has been the lack of informed financial consent. Unknown or unexpected gaps irritate people. Again, it is an economic tenet that well informed markets operate more efficiently than badly informed markets.
Why Do We Have Gaps?
We are not likely to find a solution to the problem of gaps unless we understand why we have them. The starting point is that medical gaps are something we, as a nation, have chosen to have. A public health insurance system could, at least in theory, be funded strongly enough to meet all medical costs. Ours was not:



In the private health insurance market, one problem towers above all others-the high cost of the premiums compared with the perceived value in the cover. Private health insurance confers important benefits-a chance to jump the queue and choice of doctor and/or hospital-but in the language of economics they are marginal benefits, things over and above the substantial benefit of the free public system. However, it is certainly not a marginal price. Whenever a fund member claims on his or her private health insurance, a substantial part of the payments made on his or her behalf represent Medicare benefits foregone.
If this towering problem is not fixed, nothing will save private health insurance from relegation to an insignificant role in the health financing system. After a faltering start with the PHIIS scheme, the Coalition Government has played a stronger hand with the 30% PHI rebate. There is no guarantee consumers will see this incentive as being large enough to restore value in the product, and there is little confidence it is here to stay as Labor and the Democrats are in the wings just busting their guts to get rid of it.
The medical gaps are the biggest of the smaller problems. The other smaller problems include the perverse results from community rating, the endemic over-regulation of the funds with its stifling impact, the inexplicable failure of the funds to implement efficient electronic claims and payments systems and the oligopoly which leaves the funds with little incentive to compete and be efficient.
Unless all these smaller problems are attended to, private health insurance will continue to struggle.
Implications Of Reducing PHI Gaps
If the PHI out-of-pocket medical gaps are substantially reduced, it will most likely occur as a result of a more workable gap insurance system than we have now. The implications are that:
The latter (demand inflation) problem could be ameliorated if there were greater emphasis on front-end deductible insurance, although this is no magic bullet as the lower premiums of FED policies simply reflect lower expected benefits. The "first dollar" insurance system used in Medicare is the system least able to effectively manage demand and share risk.
In summary, I am arguing here that gap insurance solves one problem by creating another in the form of more expensive PHI premiums. If PHI is to remain as part of the health financing landscape, a lasting solution to the gaps may well involve further government financial assistance. The Government's resolve to support PHI will be tested.
Implications of Not Reducing PHI Gaps
If there is a failure of will and/or a failure of policy in regard to the PHI out-of-pocket medical gaps, and if they remain or increase:
The first obstacle to a solution to the problem of the medical gaps is purely political, the difficulty of dissuading the Government from the view that Lawrence-style contracts are the only answer. This is not a matter of rhetoric. It requires first of all an opportunity to implement alternative solutions and, most importantly, to get some runs on the board.
The second obstacle to a solution is the Federal Health Department's theology in regard to doctor charging and doctor incomes. The basis of this theology is that doctors will seek to have insured rebates as high as possible, while retaining the right to charge whatever the market will bear in the way of gaps. Under this theology, any increase in benefits increases doctors' incomes but never reduces patient gaps. It is a simplistic view of the world, of course, but the data are quite supportive of their view. The Department's desire to restrain doctors' incomes is a material factor in the setting of MBS fees just as it was a material factor in their success over many years in outlawing any form of gap insurance. There is quite a lot of community and political support for their endeavors. You can test it out by offering to swap pay packets with a parliamentary backbencher. There are many who are jealous of your incomes. You know all the terms, tall poppy syndrome, and so forth. The practical upshot of this is that any gap insurance proposal which does not enhance your incomes will have a better chance of getting up than one that does.
The third obstacle is related to the second. Insurers are risk managers. They are usually quite good at passing on risk and seek to achieve as many certainties for themselves as possible. You might like to think of gap insurance without agreed fees but they won't. They want agreed fees and they want capped fees-a higher benefit in exchange for no gap. In economic terms, no gaps is a worse outcome than known gaps. No gaps increases the moral hazard of indiscriminate over-use of services, inflating demand for services. But whether it is no gap or some agreed known gap, there is still a need for a reference fee of some kind. The MBS is a poor reference point. Charging patterns are all over the place, with variations between individual practitioners, geographical variations and very marked inter-specialty variations, this latter illustrated in the following chart.

78% of services by recognised GPs are billed at or below the schedule fee. For ENT surgeons, it is 23%, and the range across all medical and surgical sub-specialties is 9% (for facio maxillary surgeons) to 99% (clinical pharmacology).
6% of services by recognised GPs are billed 30% or more above the schedule fee. For ENT surgeons, it is 45%, and the range across all medical and surgical sub-specialties is 0.3% (for rehabilitation medicine) to 54% (facio maxillary surgeons).
A nationwide agreed fee would tend to see low compliance in Sydney and Melbourne (where costs of practice and costs of living are higher) and high compliance in Adelaide (where costs of practice and costs of living are lower). "One size fits all" might work for elasticized socks. It won't work for medical gaps.
In economic terminology, what we are looking at here is the difference between a very highly differentiated personal service represented in, say, open heart surgery, and a service which is much closer in characteristics to a bulk commodity represented in, say, a computer-generated blood test. The second item fits much more easily into the conformity of the insurance framework than the first.
It is obviously desirable to seek a solution to the problem of medical gaps. If there were any simple solutions, the gaps would have been fixed long ago. Without compromises in the stances adopted by the medical profession, the funds and the health bureaucracy, the problem will not be solved. No compromises, no deal.
Thank you.
|
Australian Doctors Fund |